Dr. nahed brian
neurosurgeon
boston, MA
Dr. Brian Nahed is a distinguished neurosurgeon with a specialized focus on Brain Tumors, including Glioblastoma, Low Grade Gliomas, Meningiomas, and Metastatic Brain Tumors, as well as Brain Mapping and Intraoperative Imaging. He holds the esteemed position of Director of the Neurosurgery Residency Program at MGH and Harvard Medical School, in addition to being an Associate Professor of Neurosurgery.
Dr. Nahed's expertise lies in treating brain tumors situated in the eloquent cortex, necessitating procedures like awake surgery, language and motor mapping, and subcortical stimulation. He is also proficient in employing advanced intraoperative technology and minimally invasive techniques to effectively and safely address brain tumors.
Best neurosurgeon in boston
PLATFORM TO FIND TOP DOCTORS IN THE USA
Top surgery of Dr. Nahed
- - Awake and Language Mapping Craniotomy
-
- Brain tumors
-
- Cervical and lumbar disc degeneration
-
- Degenerative spinal conditions
-
- Glioblastoma
-
- Hemangioblastomas
Best neurosurgeon in boston, MA
neurosurgeon Surgery in boston
A native of New York, Dr. Nahed pursued his undergraduate studies in Neuroscience at UCLA, earning Phi Beta Kappa honors and garnering the department's Highest Honors. He later attended the Yale School of Medicine, where he was granted the Doris Duke Clinical Research Fellowship and graduated with honors. Dr. Nahed completed his neurosurgery residency at the renowned Massachusetts General Hospital, followed by a postdoctoral fellowship in the MGH Cancer Center under the guidance of Drs. Daniel Haber and Shyamala Maheswaran.
In 2011, Dr. Brian Nahed was recruited to join the MGH Department of Neurosurgery, MGH Brain Tumor Center, and Harvard Medical School. His research endeavors revolve around pioneering a groundbreaking blood-based test for diagnosing and monitoring brain tumors. Collaborating with Drs. Haber, Maheswaran, and Stott, Dr. Nahed produced the initial evidence of circulating tumor cells in the blood of glioblastoma patients. Supported by NIH funding, Drs. Nahed and Stott helm a laboratory dedicated to developing the inaugural blood test for individuals afflicted with brain tumors.
